CD274 and neoplasm: Importantly, ORM‐mediated PTT/SDT combined with anti‐PD‐L1 checkpoint blockade therapy significantly inhibited the growth of primary and distant tumors in triple‐negative breast cancer (TNBC) T1 tumor model mice.